TScan Therapeutics (TCRX) Insider Trading & Ownership → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free TCRX Stock Alerts $9.28 +0.09 (+0.98%) (As of 05:27 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TScan Therapeutics (NASDAQ:TCRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.76%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$266,003.10Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$64,008.00 Get TCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCRX Insider Buying and Selling by Quarter Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. TScan Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2023Timothy J BarberichDirectorBuy28,830$4.89$140,978.70 12/14/2023Barbara KlenckeDirectorBuy5,000$5.08$25,400.00 6/2/2023Timothy J BarberichDirectorBuy37,880$2.63$99,624.40 5/31/2023Lynx1 Capital Management LpMajor ShareholderSell25,400$2.52$64,008.00 (Data available from 1/1/2013 forward) TCRX Insider Trading Activity - Frequently Asked Questions Who is on TScan Therapeutics's Insider Roster? The list of insiders at TScan Therapeutics includes Barbara Klencke, Brian M Silver, David P Southwell, Gavin Macbeath, Lynx1 Capital Management Lp, Timothy J Barberich, and Zoran Zdraveski. Learn more on insiders at TCRX. What percentage of TScan Therapeutics stock is owned by insiders? 2.76% of TScan Therapeutics stock is owned by insiders. Learn more on TCRX's insider holdings. Which TScan Therapeutics insiders have been buying company stock? The following insiders have purchased TCRX shares in the last 24 months: Barbara Klencke ($25,400.00), Brian M Silver ($4,263.00), and Timothy J Barberich ($240,603.10). How much insider buying is happening at TScan Therapeutics? Insiders have purchased a total of 74,552 TCRX shares in the last 24 months for a total of $270,266.10 bought. Which TScan Therapeutics insiders have been selling company stock? The following insider sold TCRX shares in the last 24 months: Lynx1 Capital Management Lp ($64,008.00). How much insider selling is happening at TScan Therapeutics? Insiders have sold a total of 25,400 TScan Therapeutics shares in the last 24 months for a total of $64,008.00 sold. More Insider Trading Tools from MarketBeat Related Companies: OCGN Insider Ownership LXEO Insider Ownership CCCC Insider Ownership REPL Insider Ownership VYGR Insider Ownership EDIT Insider Ownership FATE Insider Ownership TSHA Insider Ownership SLDB Insider Ownership AURA Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock Lately This page (NASDAQ:TCRX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.